» Articles » PMID: 39340621

Ototoxic Effect of Nicotinamide Riboside

Overview
Publisher Springer
Specialty General Medicine
Date 2024 Sep 28
PMID 39340621
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the function of the auditory system in Wistar rats after repeated intravenous administration of nicotinamide riboside (NR). The functional activity of the receptor and retrocochlear parts of the auditory system were assessed by recording short-latency auditory evoked potentials (SLAEPs) and distortion-product otoacoustic emissions (DPOAEs) at baseline, immediately after NR administration, and 1 and 2 months later. Repeated intravenous NR administration (cumulative dose of 2700 mg/kg) to Wistar rats has a detrimental impact on the structures within the cochlear section of the auditory system.

References
1.
Fang J, Wu H, Zhang J, Mao S, Shi H, Yu D . A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation. Biomed Pharmacother. 2022; 150:113071. DOI: 10.1016/j.biopha.2022.113071. View

2.
Oh G, Kim H, Choi J, Shen A, Choe S, Karna A . Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice. Kidney Int. 2013; 85(3):547-60. PMC: 3944666. DOI: 10.1038/ki.2013.330. View

3.
Chu C . Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases. Neurobiol Dis. 2018; 122:23-34. PMC: 6396690. DOI: 10.1016/j.nbd.2018.07.015. View

4.
Qu J, Wu Y, Zhang T, Qiu Y, Ding Z, Zha D . Sirt3 confers protection against acrolein-induced oxidative stress in cochlear nucleus neurons. Neurochem Int. 2017; 114:1-9. DOI: 10.1016/j.neuint.2017.12.004. View

5.
Quan Y, Xia L, Shao J, Yin S, Cheng C, Xia W . Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway. Sci Rep. 2015; 5:8181. PMC: 4313083. DOI: 10.1038/srep08181. View